No abstract available
Plain language summary
This Medical News story examines the complexity of determining who to treat with lecanemab, the new Alzheimer disease drug.
MeSH terms
-
Alzheimer Disease* / drug therapy
-
Amyloid beta-Peptides
-
Antibodies, Monoclonal, Humanized* / therapeutic use
-
Humans
Substances
-
Amyloid beta-Peptides
-
lecanemab
-
Antibodies, Monoclonal, Humanized